System Transmission

Top Signal

100#1 JOB

Activity

2168Ripe

+909 today

System

Livenow

Terminal Asset View

stockNASDAQ

RYTM

$87.38-4.14%

Rhythm Pharmaceuticals Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

1Overripe

Live Analysis Active

Company Mission

Rhythm Pharmaceuticals creates prescription drugs for people with rare genetic conditions that cause severe obesity. Doctors prescribe these medicines to help patients manage their weight when diet and exercise alone don't work. The company makes money by selling these drugs to pharmacies, hospitals, and healthcare systems.

RYT

Industry Context

The biotech industry focuses on developing new medical treatments, often for rare diseases. Companies in this space can experience significant price swings based on clinical trial results, regulatory approvals, and investor sentiment about future drug potential.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

43Matrix

Market Momentum

34.7— Oversold / Recovery

Trend Strength

25— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

2.0x— Normal Volume

Today's Change

-4.14%— Live Performance

Social Frequency

Listening

Social Freq

0.3x

Normal Vol

X/Twitter Activity

0.3x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

EMA Distance-0

Price is overextended from the 20-day trend lead.

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

21Velocity

Live Sync

Social Intelligence Pulse.

Our engine is currently indexing RYTM across global social channels to detect early sentiment shifts and technical alignment.

XActive

RedditActive

WebActive

Social Growth+3.1% vs 7D

Signal CoverageStandard Coverage

Signal Catalysts

Intelligence Narrative Connected

Updated 12:27 PM UTC

As-of 03-15-2026 12:12 UTC

Develops drugs for rare genetic obesity disorders and makes money by selling these treatments to patients and healthcare providers.

Price below key moving averages for multiple weeks, suggesting a downtrend as sellers maintain control showing consolidation pattern.

Biotech sector faces volatility as FDA decisions approach, creating uncertainty for drug developers like Rhythm, suggesting like Rhythm.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...